Last update 16 May 2025

NXP-800

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
CCT-361814, CCT361814, NXP 800
+ [2]
Target
Action
stimulants
Mechanism
EIF2AK4 stimulants(eukaryotic translation initiation factor 2 alpha kinase 4 stimulants)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
RegulationFast Track (United States), Orphan Drug (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC32H32FN5O4
InChIKeyUBALMDIKIGDHJW-UHFFFAOYSA-N
CAS Registry1693734-80-3

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Clear cell neoplasm of ovaryPhase 1
United States
31 Dec 2021
Clear cell neoplasm of ovaryPhase 1
United Kingdom
31 Dec 2021
Endometrioid carcinoma ovaryPhase 1
United States
31 Dec 2021
Endometrioid carcinoma ovaryPhase 1
United Kingdom
31 Dec 2021
Ovarian clear cell adenocarcinomaPhase 1
United States
31 Dec 2021
Ovarian clear cell adenocarcinomaPhase 1
United Kingdom
31 Dec 2021
Platinum-Resistant Ovarian CarcinomaPhase 1
United States
31 Dec 2021
Platinum-Resistant Ovarian CarcinomaPhase 1
United Kingdom
31 Dec 2021
Platinum-Resistant, ARID1A-Mutated Ovarian CarcinomaPhase 1
United States
31 Dec 2021
Platinum-Resistant, ARID1A-Mutated Ovarian CarcinomaPhase 1
United Kingdom
31 Dec 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
Bile Duct Neoplasms
ARID1A | FGFR1 | ATM ...
-
NXP800 (35 mg/kg)
mpmomfakwq(wsooztznsp) = oypwxbrztj bvrichqvjp (fpwmibzjnn )
-
29 Apr 2025
Phase 1
Ovarian Cancer
ARID1A Mutation (Inactivating)
18
NXP800 50 mg/day
uahbsbkzoo(upoxaighiy) = ryisolujhd mzxoujdjkz (uyppxqutwr )
Positive
05 Apr 2024
NXP800 75 mg/day
uujjvhkejh(nqvvoejgii) = qjtoaoutqb cekugzyhte (pzwvoctcwl )
Phase 1
3
ekgxgibreh(fbnangygft) = cajomrlydx utfzycxwnp (ghzpwzvqzo )
Positive
14 Mar 2024
Phase 1
-
Cisplatin
usqdruhiug(wljdfykhhj) = oomgdklvzl ttzjushdjr (fgrrayzziu )
-
23 Feb 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free